• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Simulating alpha/beta selectivity at the human thyroid hormone receptor: consensus scoring using multidimensional QSAR.

作者信息

Vedani Angelo, Zumstein Martin, Lill Markus A, Ernst Beat

机构信息

Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland.

出版信息

ChemMedChem. 2007 Jan;2(1):78-87. doi: 10.1002/cmdc.200600212.

DOI:10.1002/cmdc.200600212
PMID:17096449
Abstract

We present a consensus-scoring study on the human thyroid hormone receptor alpha and beta using two receptor-modeling concepts (software Quasar and Raptor) that are based on multidimensional QSAR and allow for the explicit simulation of induced fit. The binding mode of 82 agonists and indirect antagonists, spanning an activity range of seven orders of magnitude in K(i), was identified through flexible docking to the respective X-ray crystal structures (Yeti software) and represented by a 4D data set with up to four conformations per compound. The receptor surrogates for the thyroid alpha receptor converged at a cross-validated r(2) of 0.846/0.919 (64 training compounds; for Quasar and Raptor, respectively) and yielded a predictive r(2) of 0.812/0.814 (18 test compounds); the models for the thyroid beta receptor resulted in a cross-validated r(2) of 0.823/0.909 and a predictive r(2) of 0.665/0.796, respectively. Consensus was achieved as, on average, the calculated activities of the training set differ only by a factor of 2.2 in K(i) and those of the test set by a factor of 2.8 when predicted by Quasar and Raptor, respectively.

摘要

相似文献

1
Simulating alpha/beta selectivity at the human thyroid hormone receptor: consensus scoring using multidimensional QSAR.
ChemMedChem. 2007 Jan;2(1):78-87. doi: 10.1002/cmdc.200600212.
2
Combining 4D pharmacophore generation and multidimensional QSAR: modeling ligand binding to the bradykinin B2 receptor.结合4D药效团生成与多维定量构效关系:模拟配体与缓激肽B2受体的结合
J Chem Inf Model. 2006 Sep-Oct;46(5):2135-45. doi: 10.1021/ci6001944.
3
3D-QSAR and molecular docking studies of selective agonists for the thyroid hormone receptor beta.甲状腺激素受体β选择性激动剂的3D-QSAR和分子对接研究
J Mol Graph Model. 2008 Sep;27(2):95-104. doi: 10.1016/j.jmgm.2008.03.003. Epub 2008 Mar 16.
4
Mixed-model QSAR at the human mineralocorticoid receptor: predicting binding mode and affinity of anabolic steroids.人盐皮质激素受体的混合模型定量构效关系:预测合成代谢类固醇的结合模式和亲和力。
Toxicol Lett. 2009 Sep 28;189(3):219-24. doi: 10.1016/j.toxlet.2009.05.025. Epub 2009 Jun 10.
5
Mixed-model QSAR at the glucocorticoid receptor: predicting the binding mode and affinity of psychotropic drugs.糖皮质激素受体的混合模型定量构效关系:预测精神药物的结合模式和亲和力。
ChemMedChem. 2009 Jan;4(1):100-9. doi: 10.1002/cmdc.200800274.
6
Design and synthesis of novel 3-hydroxy-cyclobut-3-ene-1,2-dione derivatives as thyroid hormone receptor beta (TR-beta) selective ligands.新型3-羟基-环丁-3-烯-1,2-二酮衍生物作为甲状腺激素受体β(TR-β)选择性配体的设计与合成
Bioorg Med Chem Lett. 2008 Jul 15;18(14):3919-24. doi: 10.1016/j.bmcl.2008.06.038. Epub 2008 Jun 14.
7
Novel ligands for the chemokine receptor-3 (CCR3): a receptor-modeling study based on 5D-QSAR.趋化因子受体-3(CCR3)的新型配体:基于5D-QSAR的受体建模研究
J Med Chem. 2005 Mar 10;48(5):1515-27. doi: 10.1021/jm040827u.
8
Only subtle protein conformational adaptations are required for ligand binding to thyroid hormone receptors: simulations using a novel multipoint steered molecular dynamics approach.配体与甲状腺激素受体结合仅需细微的蛋白质构象适应性变化:采用新型多点引导分子动力学方法的模拟研究
J Phys Chem B. 2008 Aug 28;112(34):10741-51. doi: 10.1021/jp803403c. Epub 2008 Aug 6.
9
Thyroid receptor ligands. Part 7: Indirect antagonists of the thyroid hormone receptor with improved affinity.甲状腺受体配体。第7部分:亲和力提高的甲状腺激素受体间接拮抗剂。
Bioorg Med Chem Lett. 2007 Apr 1;17(7):2018-21. doi: 10.1016/j.bmcl.2007.01.009. Epub 2007 Jan 13.
10
Atom-based 3D-QSAR, molecular docking and molecular dynamics simulation assessment of inhibitors for thyroid hormone receptor α and β.基于原子的甲状腺激素受体α和β抑制剂的3D-QSAR、分子对接及分子动力学模拟评估
J Mol Model. 2014 Jun;20(6):2286. doi: 10.1007/s00894-014-2286-5. Epub 2014 Jun 5.

引用本文的文献

1
Triclocarban, Triclosan, Bromochlorophene, Chlorophene, and Climbazole Effects on Nuclear Receptors: An and Study.三氯卡班、三氯生、溴氯酚、氯酚、克霉唑对核受体的影响:一项体外和体内研究。
Environ Health Perspect. 2020 Oct;128(10):107005. doi: 10.1289/EHP6596. Epub 2020 Oct 16.
2
Prediction of binding affinity and efficacy of thyroid hormone receptor ligands using QSAR and structure-based modeling methods.使用定量构效关系(QSAR)和基于结构的建模方法预测甲状腺激素受体配体的结合亲和力和效能。
Toxicol Appl Pharmacol. 2014 Oct 1;280(1):177-89. doi: 10.1016/j.taap.2014.07.009. Epub 2014 Jul 21.
3
Atom-based 3D-QSAR, molecular docking and molecular dynamics simulation assessment of inhibitors for thyroid hormone receptor α and β.
基于原子的甲状腺激素受体α和β抑制剂的3D-QSAR、分子对接及分子动力学模拟评估
J Mol Model. 2014 Jun;20(6):2286. doi: 10.1007/s00894-014-2286-5. Epub 2014 Jun 5.
4
TSH and Thyrotropic Agonists: Key Actors in Thyroid Homeostasis.促甲状腺激素(TSH)与促甲状腺素激动剂:甲状腺稳态的关键因素
J Thyroid Res. 2012;2012:351864. doi: 10.1155/2012/351864. Epub 2012 Dec 30.